46 Results for "

HDAC11

" in MedChemExpress (MCE) Product Catalog:
Products (46)

46 Results for "HDAC11" in MCE Product Catalog:

Cat. No.: HY-143412
CAS No.: 2217671-64-0
Purity:  ≥99.0%
Research Areas:  

Cancer

MIR002 is a potent and orally active DNA polymerase α (POLA1) and HDAC 11 dual inhibitor. MIR002 induces acetylation of p53, activation of p21, G1/S cell cycle arrest, and apoptosis. MIR002 shows significant antitumor activity in vivo .
loading...
    loading...
Cat. No.: HY-143411
CAS No.: 2487526-28-1
Research Areas:  

Cancer

GEM144 is a potent and orally active DNA polymerase α (POLA1) and HDAC 11 dual inhibitor. GEM144 induces acetylation of p53, activation of p21, G1/S cell cycle arrest, and apoptosis. GEM144 has significant antitumor activity in human orthotopic malignant pleural mesothelioma xenografts .
loading...
    loading...
Cat. No.: HY-RS06065
Research Areas:  

Others

Hdac11 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Hdac11 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS06066
Research Areas:  

Others

Hdac11 Rat Pre-designed siRNA Set A contains three designed siRNAs for Hdac11 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-15433B
CAS No.: 1083078-98-1
Synonyms: JNJ26481585 hydrochloride
Target:  

HDAC Autophagy

Research Areas:  

Cancer

Quisinostat (JNJ-26481585) hydrochloride is a potent and orally active pan-HDAC inhibitor (HDACi), with IC50 values ranging from 0.11 nM to 0.64 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11. Quisinostat hydrochloride has a broad spectrum antitumoral activity. Quisinostat hydrochloride can induce autophagy in neuroblastoma cells .
loading...
    loading...
Cat. No.: HY-115412
CAS No.: 1132749-48-4
Purity:  ≥99.0%
Synonyms: SAHA-d5; Suberoylanilide hydroxamic acid-d5
Research Areas:  

Infection Cancer

Vorinostat-d5 (SAHA-d5) is the deuterium labeled Vorinostat. Vorinostat (SAHA) is a potent and orally active pan-inhibitor of HDAC1, HDAC2 and HDAC3 (Class I), HDAC7 (Class II) and HDAC11 (Class IV), with ID50 values of 10 nM and 20 nM for HDAC1 and HDAC3, respectively. Vorinostat induces cell apoptosis . Vorinostat is also an effective inhibitor of human papillomaviruse (HPV)-18 DNA amplification .
loading...
    loading...
Cat. No.: HY-173076
Target:  

HDAC YAP

Research Areas:  

Inflammation/Immunology

HDAC11-IN-1 (Compound 14-N C6OH) is a selective macrocyclic inhibitor of HDAC11 with a Ki of 40 nM. HDAC11-IN-1 exhibits good cell permeability and can inhibit the expression of YAP1 and SOX2 .
loading...
    loading...
Cat. No.: HY-10221G
CAS No.: 149647-78-9
Synonyms: SAHA (GMP); Suberoylanilide hydroxamic acid (GMP)
Vorinostat (GMP) is a GMP grade Vorinosta (HY-10221). GMP-grade small molecules can be used as auxiliary agents in cell therapy. Vorinostat is a potent, orally available HDAC1, HDAC2, HDAC3 (Class I), HDAC6 and Inhibitors of HDAC7 (Class II) and Class IV (HDAC11) .
loading...
    loading...
Cat. No.: HY-176868
CAS No.: 2065162-16-3
Target:  

HDAC

Research Areas:  

Neurological Disease

Rodin-C is a selective HDAC inhibitor with IC50s of 0.059, 0.18   and 5.39 μM for HDAC1, HDAC2 and HDAC11, respectively, over HDAC3-10. Rodin-C significantly inhibits the HDAC-CoREST complex with low hematological toxicity. Rodin-C can be used for neurologic disorders such as Alzheimer’s disease research .
loading...
    loading...
Cat. No.: HY-169940
Target:  

HDAC

Research Areas:  

Inflammation/Immunology

Fibrostat (Compound 5n) is a selective HDAC6 inhibitor that exerts antifibrotic effects by inhibiting HDAC6 activity, with an IC50 value of 63 nM. It also exhibits good selectivity over HDAC1, HDAC3, HDAC5, HDAC8, HDAC10, and HDAC11. Fibrostat significantly downregulates fibrotic markers (fibronectin and collagen 1) in fibroblasts. Additionally, Fibrostat demonstrated no toxicity in rat-perfused heart and zebrafish larvae models. Fibrostat shows potential for research into fibrosis-related diseases .
loading...
    loading...
Cat. No.: HY-182019
HDAC11-IN-5 is a selective, potent and orally active HDAC11 inhibitor with an IC50 of 0.021 μM. HDAC11-IN-5 increases fatty acylation levels of substrate SHMT2 in AML cells. HDAC11-IN-5 induces apoptosis, G1 phase cell cycle arrest, ferroptosis, ROS production and terminal myeloid differentiation in AML cells. HDAC11-IN-5 demonstrates anti-tumor potency in an MLL-AF9-induced mouse AML model. HDAC11-IN-5 can be used for the research of cancer, such as acute myeloid leukemia .
loading...
    loading...
Cat. No.: HY-157889
CAS No.: 866123-66-2
Target:  

HDAC

Research Areas:  

Cancer

ZINC000028464438 is a selective HDAC11 inhibitor with an IC50 of 3.5 µM. ZINC000028464438 shows almost no inhibition for other HDAC subtypes .
loading...
    loading...
Cat. No.: HY-P83139
Synonyms: HDAC11; HD11; Histone deacetylase 11

Host:  

Rabbit

Application:  

WB, IP

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-170379
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

HDAC-IN-84 (compound 4d) is a potent HDAC inhibitor, with IC50 values of 0.0045, 0.015, 0.013, 0.038, 5.8 and 26 μM for HDAC1, HDAC2, HDAC3, HDAC6, HDAC8 and HDAC11, respectively. HDAC-IN-84 effectively inhibits the proliferation of leukemia cells without causing toxicity .
loading...
    loading...
Cat. No.: HY-152173
CAS No.: 3026728-28-6
Research Areas:  

Cancer

HDAC-IN-51 is a potent histone deacetylase (HDAC) inhibitor with IC50 values of 0.32, 0.353, 0.431, 0.515, and 85.4 μM for HDAC10, HDAC1, HDAC2, HDAC3 and HDAC11, respectively. HDAC-IN-51 induces cell cycle arrest and apoptosis, modulating cell cycle-/apoptosis-related miRNAs expression. HDAC-IN-51 can be used in research of cancer .
loading...
    loading...
Cat. No.: HY-109015R
CAS No.: 1616493-44-7
Synonyms: Chidamide (Standard); HBI-8000 (Standard); CS 055 (Standard)
Research Areas:  

Cancer

Tucidinostat (Standard) is the analytical standard of Tucidinostat. This product is intended for research and analytical applications. Tucidinostat (Chidamide) is a potent and orally bioavailable HDAC enzymes class I (HDAC1/2/3) and class IIb (HDAC10) inhibitor, with IC50s of 95, 160, 67 and 78 nM, less active on HDAC8 and HDAC11 (IC50s, 733 nM, 432 nM, respectively), and shows no effect on HDAC4/5/6/7/9 .
loading...
    loading...
Cat. No.: HY-12164R
CAS No.: 726169-73-9
Synonyms: MGCD0103 (Standard)
Research Areas:  

Cancer

Mocetinostat (Standard) is the analytical standard of Mocetinostat. This product is intended for research and analytical applications. Mocetinostat (MGCD0103) is a potent, orally active and isotype-selective HDAC (Class I/IV) inhibitor with IC50s of 0.15, 0.29, 1.66 and 0.59 μM for HDAC1, HDAC2, HDAC3 and HDAC11, respectively. Mocetinostat shows no inhibition on HDAC4, HDAC5, HDAC6, HDAC7, or HDAC8.
loading...
    loading...
Cat. No.: HY-159936
Target:  

HDAC PPAR Apoptosis

Research Areas:  

Cancer

CS4 is a selective HDAC inhibitor with the IC50 values of 38 nM, 12 nM, 5.8 μM, 19 μM and 61 μM against of HDAC1, HDAC6, HDAC8, HDAC4 and HDAC11, respectively. CS4 promotes α-tubulin and histone 3 acetylation. CS4 activates PPARγ and blocks glycolysis. CS4 induces cell cycle arrest at G2 phase and apoptosis, and shows anticancer effect both in vivo and in vitro .
loading...
    loading...
Cat. No.: HY-P704097
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: HDAC11; Uncharacterized Protein DKFZp434L0312; Histone Deacetylase 11; DKFZp434L0312; HD11
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P12010B
Target:  

HDAC Fluorescent Dye

Research Areas:  

Others

Ac-ETDK(myr)-AMC acetate is a DLAT-derived ε-N-myristoyllysine peptide substrate for fatty-acid deacylase HDAC11, used in fluorescence-based HDAC11 activity assays. Ac-ETDK(myr)-AMC acetate undergoes cleavage of ε-N-myristoyllysine by HDAC11, followed by trypsin-mediated cleavage of C-terminal lysine to release measurable fluorophore AMC .
loading...
    loading...